SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-12-036132
Filing Date
2012-06-22
Accepted
2012-06-22 18:32:12
Documents
1
Period of Report
2012-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v316667_4.html 4  
1 OWNERSHIP DOCUMENT v316667_4.xml 4 5800
  Complete submission text file 0001144204-12-036132.txt   7074
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Fowler Wyche JR (Reporting) CIK: 0001381064 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 12923327